# VaultMind Expert Review Sessions

Expert panel reviews of the VaultMind SRS and implementation. Each session uses a panel of domain experts with two rounds: independent review followed by cross-critique.

## Sessions

| Session | Date | Reviewing | Panel | Status |
|---------|------|-----------|-------|--------|
| [Session 01](session-01/) | 2026-04-03 | SRS v3 (pre-fixes) | 6 experts | Complete |
| [Session 02](session-02/) | 2026-04-03 | SRS v3 (post-fixes) | 7 experts | Complete |
| [Session 03](session-03/) | 2026-04-04 | Phase 1 implementation | 7 experts | Complete |
| [Session 04](session-04/) | 2026-04-06 | Full v1 implementation (Phase 1–3) | 7 experts | Complete |

## Session Structure

Each session directory contains:

```
session-NN/
├── panel.md      # Expert roster and specialties
├── round1.md     # Independent reviews from each expert
├── round2.md     # Cross-review: experts critique each other
└── summary.md    # Orchestrator synthesis with consensus/contested findings
```

## Panel Evolution

### Session 01 Panel
1. Dr. Elena Vasquez — Cognitive neuroscience, human long-term memory
2. Marcus Chen — Obsidian power user, vault architecture
3. Jordan Blackwell — Devil's advocate, systems architecture
4. Dr. Priya Sharma — Knowledge graphs, graph databases
5. Alex Novak — AI agent systems engineering
6. Sam Torres — CLI/DX design

### Session 02 Panel (changes from Session 01)
1. Dr. Elena Vasquez — Human memory *(retained)*
2. Marcus Chen — Obsidian expert *(retained)*
3. Jordan Blackwell — Devil's advocate *(retained)*
4. Dr. Priya Sharma — Graph expert *(retained)*
5. Alex Novak — Agent engineer *(retained)*
6. Sam Torres → **Kai Nakamura** — AX (AI Experience) designer *(replaced: agent-facing tool needs AX, not CLI/DX)*
7. **Dr. Lena Hoffmann** — AI/LLM memory systems researcher *(added: complements human memory with machine memory perspective)*

### Session 03–04 Panel (stable)
Same 7-expert roster as Session 02. Session 03 reviewed Phase 1 implementation. Session 04 reviewed the complete v1 (Phase 1–3).
